Plasma Erythropoietin Concentrations in Polycythaemia Vera with Special Reference to Myelosuppressive Therapy

Björn Andréasson(NU Hospital Group), Jack Kutti(Sahlgrenska University Hospital), Birgitta Swolin(Sahlgrenska University Hospital), Jan Carneskog(Karolinska University Hospital), Hans Wadenvik, Per‐Arne Lundberg(Sahlgrenska University Hospital), Göran Lindstedt(Sahlgrenska University Hospital)
Leukemia & lymphoma/Leukemia and lymphoma
January 1, 2000
10.3109/10428190009057645
Cited by 14

Related Papers

Thalassemia Syndromes
|Unknown|2009|475
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
|Blood|2011|340
Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients
|Blood|1998|306
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
|Journal of Clinical Oncology|2011|244